Product Information
ROPINIROLE HCL ER 2 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.4256 per EA under NDC 43547055403. Its NADAC has been published 196 times since Sep 28, 2022.
Strength
2 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547055403
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLEApproval Type
Generic (ANDA)
FDA Application
ANDA204413On Market Since
3/22/2022
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL ER 2 MG TABLET has been published 196 times since Sep 28, 2022, and over the history we have for it it has declined 27.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4256 per EA |
|---|---|
| All-time high | $0.6442 (Nov 13, 2024) |
| All-time low | $0.3647 (Nov 20, 2024) |
| 52-week high | $0.5217 |
| 52-week low | $0.3891 |
| Median price | $0.4746 |
| Average price | $0.4878 |
| Largest weekly change | -43.4% (Nov 20, 2024) |
| Weeks tracked | 196 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 87% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL ER 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 2 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.4256 per EA (NDC 43547055403), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL ER 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL ER 2 MG TABLET has declined 27.4%. It has been tracked across 196 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 2 MG TABLET?
Since Sep 28, 2022, the NADAC for ROPINIROLE HCL ER 2 MG TABLET has ranged from a low of $0.3647 (Nov 20, 2024) to a high of $0.6442 (Nov 13, 2024), with a median of $0.4746 per EA.
Are there cheaper alternatives to ROPINIROLE HCL ER 2 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ROPINIROLE HCL 2 MG TABLET, is $0.0562 per EA — about 87% below ROPINIROLE HCL ER 2 MG TABLET.
Who manufactures ROPINIROLE HCL ER 2 MG TABLET?
ROPINIROLE HCL ER 2 MG TABLET (NDC 43547055403) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification